Acurable raises €11m in Series A funding round
London, 3rd October 2022
Acurable, an award-winning wearable medical devices company, today announced an €11m investment as a …
AcuPebble SA100 offers automated sleep apnoea diagnosis equivalent to cardiorespiratory polygraphy
London, 26th January 2022
AcuPebble SA100 is clinically equivalent to cardiorespiratory polygraphy for the automated diagnosis …
Acurable receives US FDA clearance for its home sleep apnoea testing device AcuPebble SA100
London, 29th November 2021
AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect …